Hepatitis C Virus Infection and Kidney Transplantation A Review for Clinicians

被引:0
作者
Einollahi, Behzad [1 ]
Alavian, Seyed-Moayed [2 ]
机构
[1] Baqiyatallah Univ Med Sci, Nephrol & Urol Res Ctr, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Baqiyatallah Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
关键词
hepatitis C virus; kidney transplant recipients; survival analysis; RENAL-ALLOGRAFT RECIPIENTS; POSTTRANSPLANTATION DIABETES-MELLITUS; RECOMBINANT INTERFERON-ALPHA; HEMODIALYSIS-PATIENTS; ANTIVIRAL THERAPY; VIRAL-HEPATITIS; HCV INFECTION; DIALYSIS PATIENTS; LIVER HISTOLOGY; ANTI-HCV;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis C virus (HCV) infection is frequent among kidney transplant recipients, and it is currently the major cause of chronic liver disease following kidney transplantation. The presence of HCV infection has been found to negatively affect the morbidity and mortality rates in patients on dialysis, as well; it seems that kidney transplantation is a reasonable treatment option after a careful pretransplant evaluation. Nevertheless, there are several questions about the indications of kidney transplantation, pretransplant evaluation, transplantation from HCV-infected donors, patient and graft survival rates, and kidney diseases associated with hepatitis C virus after kidney transplantation. This review deals with the most current information on pretransplant and posttransplant evaluations, complications, treatment, and prognosis of HCV-infected kidney transplant recipients. IJKD 2010;4:1-8 www.ijkd.org
引用
收藏
页码:1 / 8
页数:8
相关论文
共 75 条
[11]  
Chen Stephen L, 2006, Int J Med Sci, V3, P47
[12]   Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement [J].
Covic, Adrian ;
Abramowicz, Daniel ;
Bruchfeld, Annette ;
Leroux-Roels, Geert ;
Samuel, Didier ;
van Biesen, Wim ;
Zoccali, Carmine ;
Zoulim, Fabien ;
Vanholder, Raymond .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) :719-727
[13]   Hepatitis C virus infection and de novo glomerular lesions in renal allografts [J].
Cruzado, JM ;
Carrera, M ;
Torras, J ;
Grinyó, JM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (02) :171-178
[14]   Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance [J].
Cruzado, JM ;
Casanovas-Taltavull, T ;
Torras, J ;
Baliellas, C ;
Gil-Vernet, S ;
Grinyó, JM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (03) :357-360
[15]   Absence of HCV viraemia in anti-HCV-negative haemodialysis patients [J].
Dalekos, GN ;
Boumba, DS ;
Katopodis, K ;
Zervou, E ;
Sferopoulos, G ;
Elisaf, M ;
Tsianos, EV ;
Siamopoulos, KC .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (07) :1804-1806
[16]  
DRUWE PM, 1994, NEPHROL DIAL TRANSPL, V9, P230
[17]   Iranian model of renal allograft transplantation in 3028 recipients: Survival and risk factors [J].
Einollahi, B. ;
Pourfarziani, V. ;
Ahmadzad-Asl, M. ;
Lessan-Pezeshki, M. ;
Davoudi, A. ;
Nourbala, A. ;
Shariat-Moghani, S. ;
Nemati, E. ;
Poor-Reza-Gholi, F. F. ;
Simforoosh, N. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (04) :907-910
[18]   Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients [J].
Einollahi, B ;
Hajarizadeh, B ;
Bakhtiari, S ;
Lesanpezeshki, M ;
Khatami, MR ;
Nourbala, MH ;
Pourfarziani, V ;
Alavian, SM .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (07) :836-840
[19]   Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients [J].
Fabrizi, F. ;
Lunghi, G. ;
Dixit, V. ;
Martin, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (10) :1413-1422
[20]   Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation [J].
Fabrizi, F ;
Lampertico, P ;
Lunghi, G ;
Mangano, S ;
Aucella, F ;
Martin, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) :623-632